SmarTrial vs eMIMSplus Asia

SmarTrial streamlines project and communications among Sponsors, CROs and Sites in clinical trials

With over 60 years of being the go-to medicine information provider, CIMS Medica/MIMS presents the most comprehensive and easy-to-use digital medicine and drug reference platform — eMIMSplus. eMIMSplus provides access to over 100,000 drugs approved in India, presented in a clinically relevant format, along with the following key features: 1. MIMS Interaction Checker to identify: a. Potentially harmful combinations of medicines b. Medicines that may be unsuitable due to the patient’s allergy profile c. Medicines that may be unsuitable due to a pre-existing health condition 2. A compilation of regionally and internationally referenced Disease Management Guides across more than 16 specialties 3. Clinical Tables, classified by category of medicine 4. CME/CPD (accredited and unaccredited) courses available online 5. MIMS Medical News & Updates 6. Medicine Interactions involving Cytochrome P450 enzymes 7. Clinical Calculators, equations, and scoring tools across 15 categories 8. Future tools to help identify medicines that may be potentially unsafe during pregnancy or lactation 9. A medicine database updated quarterly Safer Medicines, Better Care Disclaimer: eMIMSplus is strictly intended for use by healthcare professionals — including doctors, nurses, pharmacists, and medical students. For more information: https://cds.mims.com/emimsplus/ To access the platform: https://cds.emims.plus/ For support: subscriptions.cds@cims.co.in Phone: +918064532805/+918064532806 Available: Monday to Friday, 10:00 AM – 6:00 PM IST